A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2017; you can also visit the original URL.
The file type is application/pdf
.
Once-weekly liposomal amphotericin B for prophylaxis of invasive fungal infection after graft-versus-host disease in allogeneic hematopoietic stem cell transplantation: a comparative retrospective single-center study
2010
Hematology/Oncology and Stem Cell Therapy
BACKGROUND AND OBJECTIVES: the liposomal formulation of amphotericin b (lamb) has been shown to cause few and mild infusion-related reactions, while achieving high plasma and tissue concentrations compared with conventional amphotericin b. We investigated the efficacy and safety of high-dose lamb (7.5 mg/kg once weekly) prophylaxis of fungal infections in allogeneic stem-cell transplanted (allo-sct) patients with graft-ver-sus-host disease (Gvhd). DESIGN AND SETTING: retrospective, comparative,
doi:10.5144/1658-3876.2010.167
fatcat:6qxgl4fimfhthi5d7pofo62lx4